Company profile
Nuvectis Pharma, Inc. Insider Trading
NVCTEvery SEC Form 4 insider trading filing for Nuvectis Pharma, Inc. (NVCT) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001875558
- Filings
- 80
- Insiders
- 9
- Last filing
- 2026-08-03
Activity summary
No insider transactions in the last 30 days. The most recent was on August 3, 2026, when Michael J. Carson reported 30,000 shares (Award). 80 filings from 9 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Nuvectis Pharma, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.2M.
90 day insight
Over the last 90 days, Nuvectis Pharma, Inc. insiders bought $1.2M across 2 transactions with no open-market sales.
- Most active insider: Marlio Charles Mosseri with 1 transaction totaling $916K.
- Largest single purchase: $916K by Marlio Charles Mosseri on Jun 30, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 50 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Marlio Charles Mosseri | NVCT | Purchase | 50,000 | $18.32 | $916K |
| Jun 30, 2026 | Ron Bentsur | NVCT | Purchase | 12,500 | $20.00 | $250K |
| Oct 27, 2025 | Marlio Charles Mosseri | NVCT | Purchase | 72,836 | $6.28 | $457K |
| Oct 23, 2025 | Marlio Charles Mosseri | NVCT | Purchase | 46,900 | $6.06 | $284K |
| Feb 7, 2025 | Marlio Charles Mosseri | NVCT | Purchase | 240,000 | $5.00 | $1.20M |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=NVCT" \
-H "X-Api-Key: $KEY"Top insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Nuvectis Pharma, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →